RazorMetrics Inc.

Based in the US, RazorMetrics Inc. provides a comprehensive pharmacy cost containment platform aimed at reducing drug spending for employers, payors, and pharmacy benefit managers (PBMs). RazorMetrics Inc. is a company focused on pharmacy cost management, founded in 2018 and headquartered in Austin, US.

The firm has undergone no pivots or major operational changes since its inception. The company was founded by Tom Dorsett, who has experience in leading other healthcare-related ventures. RazorMetrics raised USD 6. 00 mn in Series A funding on April 20, 2021, led by Sopris Venture Capital and with participation from individual investors, bringing the total amount raised to USD 6.

00 mn. RazorMetrics offers a pharmacy cost containment platform that significantly reduces drug spending for employers, payors, and PBMs. The core of their service is RazorCodex™, an automated solution that integrates into prescribers' workflows, enhancing healthcare decisions and lowering medication costs. Utilizing artificial intelligence, the platform identifies and applies all available savings options, effectively managing the rising costs of pharmaceuticals.

Since its launch in 2018, RazorMetrics has catered to a varied clientele, including large employers and health plans across the US, focusing on tailored healthcare cost management strategies. RazorMetrics operates on a B2B model through partnerships with healthcare organizations, such as employers and payors. Their financial model includes subscription agreements for access to RazorCodex™ and related services, allowing clients to benefit from continual updates and support. Implementation incurs no costs, and clients can expect a return on investment within the first year, with a guarantee of savings commencing within 120 days of deployment.

Revenue is closely linked to the effectiveness of their solutions, ensuring high client satisfaction and retention. In April 2021, RazorMetrics Inc. raised USD 6. 00 mn in Series A funding, which will be utilized to expand operations in response to their rapid growth.

The company plans to enhance its product offerings and may explore new geographic markets, although specific regions have not been disclosed. Tom Dorsett will continue as CEO, leading the company through this growth phase.